Tag: SBS

Computer Vision/Deep Learning Scientist – SBS Corp.

Computer Vision/Deep Learning ScientistRemote DescriptionComputer Vision/Deep Learning Scientist work with various product teams across various business units to define high-impact business problems, solve them using novel techniques, and execute and monitor them throughout their lifecycle.Require to design, develop, and implement novel computer vision algorithms for unique use cases.Evaluate accuracy and…

Continue Reading Computer Vision/Deep Learning Scientist – SBS Corp.

Principal Scientist I Bioinformatics Job Opening in Santa Clara, CA at Roche Holdings Inc.

The Position Roche Sequencing Solutions (RSS), a business within Roche Diagnostics, focused on developing a disruptive Next-Generation Sequencing (NGS) platform along with a portfolio of reagents, assays and informatics solutions for multiple disease areas. We are looking for a Principal Bioinformatics Scientist in the NGS Algorithms and Applications team to…

Continue Reading Principal Scientist I Bioinformatics Job Opening in Santa Clara, CA at Roche Holdings Inc.

Third Generation Sequencing Market Set to Witness

LONDON, June 06, 2023 (GLOBE NEWSWIRE) — The newest report from Data Bridge Market Research, “Third Generation Sequencing Market” examines growth strategies, drivers, opportunities, key segments, Porter’s Five Forces analysis, and the competitive environment in detail. In order to thrive in the rapidly evolving marketplace, businesses today require innovative and…

Continue Reading Third Generation Sequencing Market Set to Witness

A Guide to DNA Sequencers

DNA sequencing is a method that determines the order of the four nucleotide bases, namely, adenine (A), thymine (T), guanine (G), and cytosine (C), that form a DNA molecule. In this article, AZoLifeSciences offers a comprehensive guide to DNA Sequencers. Image Credit: Blue Andy/Shutterstock.com In a DNA double helix, nucleotide bases…

Continue Reading A Guide to DNA Sequencers

Illumina Complete Long Reads software analysis workflow for human WGS

Introduction Next-generation sequencing (NGS) enables scientists to decipher the genome for a deeper understanding of biology. Proven Illumina sequencing by synthesis (SBS) chemistry combined with award-winning DRAGEN secondary analysis delivers whole-genome sequencing (WGS) data with outstanding accuracy.1,2 DRAGEN Multigenome (graph) further improves mapping accuracy in challenging regions by ~50%.1 Still,…

Continue Reading Illumina Complete Long Reads software analysis workflow for human WGS

High Cost of Advanced Infrastructure for Sequencing Fuels the Sector

DUBLIN, May 29, 2023 /PRNewswire/ — The “Global Microbiome Sequencing Services Market by Service (Sample Preparation, Sequencing, Library Preparation), Type (Amplicon Sequencing, Whole Genome Sequencing), Technology (Sequencing by Synthesis, Nanopore Sequencing), End User – Forecast to 2028” report has been added to  ResearchAndMarkets.com’s offering. The microbiome sequencing services market is projected…

Continue Reading High Cost of Advanced Infrastructure for Sequencing Fuels the Sector

Global Microbiome Sequencing Services Market Report 2023: High Cost of Advanced Infrastructure for Sequencing Fuels the Sector

DUBLIN, May 29, 2023 /PRNewswire/ — The “Global Microbiome Sequencing Services Market by Service (Sample Preparation, Sequencing, Library Preparation), Type (Amplicon Sequencing, Whole Genome Sequencing), Technology (Sequencing by Synthesis, Nanopore Sequencing), End User – Forecast to 2028” report has been added to  ResearchAndMarkets.com’s offering.   The microbiome sequencing services market is…

Continue Reading Global Microbiome Sequencing Services Market Report 2023: High Cost of Advanced Infrastructure for Sequencing Fuels the Sector

Gene Editing Service Market 2023 Proclaims Tremendous Revenue

Gene Editing Service Market Gene editing is also called genome editing. It is a group of technologies that permit researchers to make a change in the DNA of organisms. Currently, there are several approaches are being developed for gene editing. One of the popular gene editing technologies is the CRISPR-Cas9…

Continue Reading Gene Editing Service Market 2023 Proclaims Tremendous Revenue

Increasing Demand for Metagenomic Sequencing Drives Growth

Company Logo Global Microbiome Sequencing Services Market Global Microbiome Sequencing Services Market Dublin, May 29, 2023 (GLOBE NEWSWIRE) — The “Global Microbiome Sequencing Services Market by Service (Sample Preparation, Sequencing, Library Preparation), Type (Amplicon Sequencing, Whole Genome Sequencing), Technology (Sequencing by Synthesis, Nanopore Sequencing), End User – Forecast to 2028”…

Continue Reading Increasing Demand for Metagenomic Sequencing Drives Growth

Global Microbiome Sequencing Services Market Report 2023:

Dublin, May 29, 2023 (GLOBE NEWSWIRE) — The “Global Microbiome Sequencing Services Market by Service (Sample Preparation, Sequencing, Library Preparation), Type (Amplicon Sequencing, Whole Genome Sequencing), Technology (Sequencing by Synthesis, Nanopore Sequencing), End User – Forecast to 2028” report has been added to ResearchAndMarkets.com‘s offering. The microbiome sequencing services market…

Continue Reading Global Microbiome Sequencing Services Market Report 2023:

NGS-Based RNA-sequencing Markets: Sample Preparation, Platforms & Consumables, Services, Data Analysis, De Novo, Epigenetics, Small RNA

Company Logo Global NGS-Based RNA-Sequencing Market Global NGS-Based RNA-Sequencing Market Dublin, May 26, 2023 (GLOBE NEWSWIRE) — The “NGS-Based RNA-sequencing Market by Product & Services (Sample Preparation, Platforms & Consumables, Services, Data Analysis), Technology (SBS, SMRT, Nanopore), Application (De Novo, Epigenetics, Small RNA), End-User, Region – Global Forecast to 2027”…

Continue Reading NGS-Based RNA-sequencing Markets: Sample Preparation, Platforms & Consumables, Services, Data Analysis, De Novo, Epigenetics, Small RNA

Four MORE Chinese DNA Sequencing Startups

Yesterday I wrote about eight Chinese DNA sequencing companies. Today I found out about 4 more! So let’s very quickly review! Looks like Illumina-style SBS using an unspecified surface amplification approach. According to their website: Q30>85%, run outputs up to 300Gb. Two instruments, the Salus Pro and Salus Evo. Seems…

Continue Reading Four MORE Chinese DNA Sequencing Startups

Ironwood acquires VectivBio in $1B deal

Ironwood Pharmaceuticals, Inc., a GI-focused healthcare company, and VectivBio Holding AG, a clinical-stage biopharmaceutical company pioneering novel, transformational treatments for severe rare gastrointestinal conditions, have entered into a definitive agreement for Ironwood to acquire VectivBio for $17.00 per share in an all-cash transaction with an estimated aggregate consideration of approximately…

Continue Reading Ironwood acquires VectivBio in $1B deal

NGS Sample Preparation Market is expected to advance at a CAGR of 13.7% from 2022 to 2032

[342 Pages Report] The global NGS sample preparation market is expected to be valued at $5441.1 million by 2032, up from $1321.8 million in 2022, and to grow at a 13.7% CAGR during the forecast period (2022-2032). DNA contains the blueprints of life. Within its structures are the codes required for the…

Continue Reading NGS Sample Preparation Market is expected to advance at a CAGR of 13.7% from 2022 to 2032

Sequencing 101: Sequencing coverage – PacBio

 This article explores sequencing coverage fundamentals. Uncover key concepts and discover how highly accurate long-read sequencing provides a comprehensive view of the genome, at any coverage level.  What is sequencing coverage? Genomics professionals use the terms “sequencing coverage” or “sequencing depth” to describe the number of unique sequencing reads that…

Continue Reading Sequencing 101: Sequencing coverage – PacBio

Microbiome Sequencing Services Market Production, Revenue, Price, Trend, Size and Growth Analysis 2032

The Microbiome Sequencing Services Market Size, Scope, and Forecast 2023-2032 report has been added to the Market research collection of Quince Market Insights. Industry experts and researchers have offered an authoritative and concise analysis of the Microbiome Sequencing Services Market with respect to various aspects such as growth factors, challenges, restraints, developments, and opportunities for growth. This…

Continue Reading Microbiome Sequencing Services Market Production, Revenue, Price, Trend, Size and Growth Analysis 2032

The Glue of Genomics: Will Science’s Unsung Data Heroes Abandon Academia?

Advances in the last twenty years of genomics have turbocharged our ability to decode DNA and other nucleic acids. At the turn of the century, the Human Genome Project completed a 13-year journey to produce the first complete human genome at a great financial cost. In 2023, genome sequencing is a routine…

Continue Reading The Glue of Genomics: Will Science’s Unsung Data Heroes Abandon Academia?

Difference between variants called in sequences with 2-channel SBS and 4-channel SBS

Difference between variants called in sequences with 2-channel SBS and 4-channel SBS 0 Hi all. I have been using 4-channel SBS for sample sequencing and am considering using 2-channel SBS in the future. I would like to know if there are any papers that discuss the differences in SNPs obtained…

Continue Reading Difference between variants called in sequences with 2-channel SBS and 4-channel SBS

Genetic immune escape landscape in primary and metastatic cancer

Inference of HLA-I tumor status with LILAC Inference of the correct HLA-I tumor status is fundamental to identifying GIE alterations (Fig. 1a), to estimate the neoepitope repertoire and burden and to predict the response to immune checkpoint inhibitors14,15 (ICIs). We have developed LILAC, a framework that performs HLA-I typing for…

Continue Reading Genetic immune escape landscape in primary and metastatic cancer

Clinical Oncology Next-generation Sequencing Market is projected to expand at a prolific CAGR of 16.3% reaching a valuation of US$ 1.14 Billion by 2029

The Clinical Oncology Next-generation Sequencing Market is anticipated to reach US$ 449.4 Million in value by 2022. The total market is anticipated to grow at a remarkable CAGR of 16.3% between 2022 and 2029, reaching a valuation of US$ 1.14 Billion by 2029, due to the increasing implementation of next…

Continue Reading Clinical Oncology Next-generation Sequencing Market is projected to expand at a prolific CAGR of 16.3% reaching a valuation of US$ 1.14 Billion by 2029

Jaguar Health : Completes Enrollment in its Pivotal Phase 3 OnTarget Trial of Crofelemer for Prophylaxis of Cancer Therapy-Related Diarrhea – Form 8-K

Jaguar Completes Enrollment in its Pivotal Phase 3 OnTarget Trial of Crofelemer for Prophylaxis of Cancer Therapy-Related Diarrhea Primary endpoint based on patient reported outcomes from study expected in October 2023 With the completion of the PIPE financing of unregistered shares and 6-month lock up term, Jaguar has agreed, as…

Continue Reading Jaguar Health : Completes Enrollment in its Pivotal Phase 3 OnTarget Trial of Crofelemer for Prophylaxis of Cancer Therapy-Related Diarrhea – Form 8-K

Jaguar Completes Enrollment in Its Pivotal Phase 3 OnTarget Trial of Crofelemer for Prophylaxis of Cancer Therapy-Related Diarrhea

Primary endpoint based on patient reported outcomes from study expected in October 2023 With the completion of the PIPE financing of unregistered shares and 6-month lock up term, Jaguar has agreed, as described below, not to issue additional equity securities before October 22, 2023 – by which point the Company…

Continue Reading Jaguar Completes Enrollment in Its Pivotal Phase 3 OnTarget Trial of Crofelemer for Prophylaxis of Cancer Therapy-Related Diarrhea

Principal scientist bioinformatics – Urgent Role at Roche in Washington DC

We are looking to hire a resourceful Principal scientist bioinformatics to join our incredible team at Roche in Washington DC.Growing your career as a Full Time Principal scientist bioinformatics is an incredible opportunity to develop excellent skills.If you are strong in presentation, adaptability and have the right mindset for the…

Continue Reading Principal scientist bioinformatics – Urgent Role at Roche in Washington DC

NGS-based RNA Sequencing Market Expected to Reach USD 19.68 Billion by 2032

Reports And Data The global National-Generation Sequencing (NGS)-based RNA sequencing market size is expected to reach USD 19.68 Billion in 2032 NEW YORK, NY, UNITED STATES, May 2, 2023 /EINPresswire.com/ — The global NGS-Based RNA Sequencing Market sequencing had a value of USD 3.54 Billion in 2022 and is projected…

Continue Reading NGS-based RNA Sequencing Market Expected to Reach USD 19.68 Billion by 2032

NGS Sample Preparation Market is projected to advance at a CAGR of 13.7% from 2022 to 2032 | FMI Study

[342 Pages Report] The global NGS sample preparation market is expected to be valued at $5441.1 million by 2032, up from $1321.8 million in 2022, and to grow at a 13.7% CAGR during the forecast period (2022-2032). DNA contains the blueprints of life. Within its structures are the codes required for the…

Continue Reading NGS Sample Preparation Market is projected to advance at a CAGR of 13.7% from 2022 to 2032 | FMI Study

Illumina, under pressure from Icahn, outlines plan to reduce more expenses

By the numbers Q1 Revenue: $1.09 billion 11% decrease year-over-year Q1 Net income: $3 million 96.5% decrease year-over-year Q1 Diluted earnings per share (GAAP): $0.02 96.4% decrease year-over-year Q1 Insights: Illumina, a global leader in DNA sequencing, said it plans to cut costs by $100 million this year as it…

Continue Reading Illumina, under pressure from Icahn, outlines plan to reduce more expenses

Global MiRNA sequencing market is expected to register a revenue CAGR of 12% during the Forecast period 2032

Reports And Data The global Micro Ribonucleic Acid (MiRNA) sequencing assay market size is expected to register a revenue CAGR of 12% during the forecast period 2032. NEW YORK, NY, UNITED STATES, April 23, 2023 /EINPresswire.com/ — The Global MiRNA Sequencing Assay Market sequencing assays was valued at USD 594.16…

Continue Reading Global MiRNA sequencing market is expected to register a revenue CAGR of 12% during the Forecast period 2032

NGS Data Analysis Market Sales to Reach US$ 2,314.7 Million by 2032; Rising Demand in Genomics Research Boosts the Growth

PRESS RELEASE Published April 21, 2023 According to Fact.MR, a market research and competitive intelligence provider, the global NGS data analysis market is estimated at US$ 561.4 Million in 2022 and is expected to expand at an impressive CAGR of 15.2% during the forecast years of 2022-2032. The market is…

Continue Reading NGS Data Analysis Market Sales to Reach US$ 2,314.7 Million by 2032; Rising Demand in Genomics Research Boosts the Growth

VAMOS! Discover hidden VNTRs with long reads

 See how the Chaisson lab created a new method to characterize human VNTR variation with PacBio long-read sequencing.  Structural variants are hard to find with short-read sequencing methods At present, most genomic researchers worldwide use short-read sequencing methods based on aging sequencing-by-synthesis (SBS) technology. However, short reads are unable to…

Continue Reading VAMOS! Discover hidden VNTRs with long reads

Roche hiring Principal Scientist II Bioinformatics in Mississauga, Ontario, Canada

The PositionRoche Sequencing Solutions (RSS), a business within Roche Diagnostics, focused on developing a disruptive Next-Generation Sequencing (NGS) platform along with a portfolio of reagents, assays and informatics solutions for multiple disease areas. We are looking for a Principal Bioinformatics Scientist in the NGS Algorithms and Applications team to support…

Continue Reading Roche hiring Principal Scientist II Bioinformatics in Mississauga, Ontario, Canada

Clinical Oncology Next-generation Sequencing Market grow at a CAGR 16.3% from 2022 to 2029

The Clinical Oncology Next-generation Sequencing Market is anticipated to reach US$ 449.4 Mn in value by 2022. The total market is anticipated to grow at a remarkable CAGR of 16.3% between 2022 and 2029, reaching a valuation of US$ 1.14 Bn by 2029, due to the increasing implementation of next…

Continue Reading Clinical Oncology Next-generation Sequencing Market grow at a CAGR 16.3% from 2022 to 2029

Transfection Reagent and Equipment Market is Valued at USD 2,284,494.00 Thousand at a CAGR of 9.6% During the Forecast Period 2030

PRESS RELEASE Published April 11, 2023 The wide-ranging Transfection Reagent and Equipment Market report has been generated with inputs from a team of experts based on detailed market analysis. This market analysis report contains insights into the market definition, classifications, applications, and engagements. The report also includes historic data, present…

Continue Reading Transfection Reagent and Equipment Market is Valued at USD 2,284,494.00 Thousand at a CAGR of 9.6% During the Forecast Period 2030

Advancing Cancer Research with Multiomics

Advancing Cancer Research with Multiomics April 7, 2023 Learn how researchers at the Ontario Institute for Cancer Research and United Health Network are linking the causes and consequences of complex phenotypes through multiomics to enable discoveries that weren’t possible before. Subscribe to the Illumina video channel www.youtube.com/subscription_center?add_user=IlluminaInc A global genomics…

Continue Reading Advancing Cancer Research with Multiomics

Transforming Oncology with Genomics

Transforming Oncology with Genomics April 7, 2023 Researchers from the Ontario Institute for Cancer Research and United Health Network share how knowing more about cancer biology through genomic studies is enabling universities and health systems to advance the fight against cancer. Subscribe to the Illumina video channel www.youtube.com/subscription_center?add_user=IlluminaInc A global…

Continue Reading Transforming Oncology with Genomics

Gene Editing Service Market is estimated to reach USD 18.77

Gene Editing Service Market is estimated to reach USD 18.77 Billion by 2030 : Cognitive Market Research Market Overview: – What is gene editing? Gene editing is also called genome editing. It is a group of technologies that permit researchers to make a change in the DNA of organisms. Currently,…

Continue Reading Gene Editing Service Market is estimated to reach USD 18.77

High-quality single amplicon sequencing method for illumina MiSeq platform using pool of ‘N’ (0-10) spacer-linked target specific primers without PhiX spike-in

Background: Illumina sequencing platform requires base diversity in the initial 11 cycles for efficient cluster identification and colour matrix estimation. This limitation yields low-quality data for amplicon libraries having homogeneous base composition. Spike-in of PhiX library ensures base diversity but reduces the overall number of sequencing reads for data analysis….

Continue Reading High-quality single amplicon sequencing method for illumina MiSeq platform using pool of ‘N’ (0-10) spacer-linked target specific primers without PhiX spike-in

Cambridge: City of Innovation – The ‘beer summit’ that generated a genomic revolution

When you hear Next Generation Sequencing (NGS), you think Illumina Inc. Illumina is widely regarded as the giant of NGS, with an estimated 80% share of the global gene sequencing market. At the heart of Illumina’s nucleic acid sequencing technologies is sequencing-by-synthesis (SBS), a chemistry technology with a humble and…

Continue Reading Cambridge: City of Innovation – The ‘beer summit’ that generated a genomic revolution

Illumina (ILMN) Unveils Complete Long Reads Technology

Illumina, Inc. ILMN recently launched its first product based on its novel Illumina Complete Long Read technology. The high-performance, long-read, human whole-genome sequencing (WGS) assay – Illumina Complete Long Read is well-suited with Illumina NovaSeq X Plus, NovaSeq X, and NovaSeq 6000 Sequencing Systems. More on the News Illumina’s Complete…

Continue Reading Illumina (ILMN) Unveils Complete Long Reads Technology

Illumina (ILMN) Unveils Complete Long Reads Technology – March 15, 2023

Illumina, Inc. (ILMN Quick QuoteILMN – Free Report) recently launched its first product based on its novel Illumina Complete Long Read technology. The high-performance, long-read, human whole-genome sequencing (WGS) assay – Illumina Complete Long Read is well-suited with Illumina NovaSeq X Plus, NovaSeq X, and NovaSeq 6000 Sequencing Systems. More…

Continue Reading Illumina (ILMN) Unveils Complete Long Reads Technology – March 15, 2023

To Q40 and Beyond: Sequencing’s Accuracy Revolution is Happening Now

NEW YORK – During beta testing for Element Biosciences’ new sequencer last year, one of the customers quickly ran into a problem when trying it out with 10x Genomics’ single-cell assays. 10x’s Cell Ranger software, used for single-cell sequencing data analysis, was aborting runs and spitting out error messages. The reason?…

Continue Reading To Q40 and Beyond: Sequencing’s Accuracy Revolution is Happening Now

Phylogenomic analysis of the plastid genome of the Peruvian purple maize zea mays subsp. mays cv. ‘INIA 601’

Title:  Phylogenomic analysis of the plastid genome of the Peruvian purple maize zea mays subsp. mays cv. ‘INIA 601’ Authors:  Montenegro, Juan D.Julca, IreneChumbe-Nolasco, Lenin D.Rodríguez-Pérez, Lila M.Panizo, Ricardo SevillaMedina-Hoyos, AliciaGutiérrez-Reynoso, Dina L.Guerrero-Abad, Juan CarlosGuerra, Carlos A. AmasifuenGarcía-Serquén, Aura L. Keywords:  Science::Biological sciences Issue Date:  2022 Source:  Montenegro, J. D.,…

Continue Reading Phylogenomic analysis of the plastid genome of the Peruvian purple maize zea mays subsp. mays cv. ‘INIA 601’

New genetic avenues for treatment in diffuse large B-cell lymphoma

New genetic avenues for treatment in diffuse large B-cell lymphoma Scientists from the NTU School of Biological Sciences (SBS) have revealed new avenues in diffuse large B-cell lymphoma (DLBCL) protein pathways that allow for more targeted treatments, thus paving the way in reducing the relapse or refractory occurrences in DLBCL…

Continue Reading New genetic avenues for treatment in diffuse large B-cell lymphoma

Takeda Presents Positive Results from Phase 3 Study of Vedolizumab for Prevention of Intestinal Acute Graft-Versus-Host Disease (aGvHD) in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)

ift.tt/l0QkUe2 Business Wire India The Phase 3 GRAPHITE Study Met Its Primary Efficacy Endpoint of Significant and Clinically Meaningful Intestinal aGvHD-Free Survival as Compared to Placebo by Day 180 after Allo-HSCT (p<0.001) No New Safety Signals Were Seen with Vedolizumab Compared with Placebo in Patients Who Received Allo-HSCT Data Were…

Continue Reading Takeda Presents Positive Results from Phase 3 Study of Vedolizumab for Prevention of Intestinal Acute Graft-Versus-Host Disease (aGvHD) in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)

Innovative technologies crowd the short-read sequencing market

There’s an old saying in the field of technology: “Nobody ever got fired for buying IBM” — a reference to the company’s once-ubiquitous computers. Replace IBM with Illumina, a biotechnology company in San Diego, California, and the same could be said of DNA sequencing today. Keith Robison, a computational biologist…

Continue Reading Innovative technologies crowd the short-read sequencing market

United States DNA Sequencing Products Market Share, Growth |

According to the latest report by IMARC Group “United States DNA Sequencing Products Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”. The United States DNA sequencing products market size reached US$ 2.3 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 5.5 Billion by…

Continue Reading United States DNA Sequencing Products Market Share, Growth |

Tuesday, Feb. 14, 2023, San Diego Metro Magazine

Genentech begins $450 million expansion in Oceanside to make new drugs for rare diseases By Chris Jennewein | Times of San Diego Genentech has begun a $450 million expansion of its biotech campus in Oceanside with a new facility that will produce complex drugs for rare diseases and personalized medicine….

Continue Reading Tuesday, Feb. 14, 2023, San Diego Metro Magazine

Microbiome Sequencing Services Market Size, Trends, Growth, Analysis and Forecast 2022-2027

PRESS RELEASE Published February 13, 2023  According to the latest report by IMARC Group, titled, “Microbiome Sequencing Services Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027“, The global microbiome sequencing services market size reached US$ 1,537.3 Million in 2021. Looking forward, the market expected to reach US$…

Continue Reading Microbiome Sequencing Services Market Size, Trends, Growth, Analysis and Forecast 2022-2027

AGBT: Illumina Offers First Look Under the Hood for Complete Long Reads Product

HOLLYWOOD, Florida – Illumina provided the first explanation for how its new Complete Long Reads (CLR) product will work as well as some customer data and testimonials at a Wednesday workshop here at the Advances in Genome Biology and Technology annual meeting. First, DNA molecules are tagmented to generate long…

Continue Reading AGBT: Illumina Offers First Look Under the Hood for Complete Long Reads Product

Illumina delivers first NovaSeq X Plus sequencer to the Broad Institute

New data on NovaSeq X Plus and workflow insights on Illumina Complete Long Reads unveiled at AGBT HOLLYWOOD, Fla., Feb. 8, 2023 /PRNewswire/ — Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced that its first NovaSeq X Plus system was recently delivered to…

Continue Reading Illumina delivers first NovaSeq X Plus sequencer to the Broad Institute

Spatial and NGS Dominate Proceedings at AGBT 2022

Attending the Advances in Genome Biology and Technology (AGBT) meeting in June 2022 in Orlando, FL, was like drinking from a firehose of genomic information. Or rather, two firehoses. The first let loose a steady stream of information about progress in spatial biology. Speakers shared their excitement over new discoveries,…

Continue Reading Spatial and NGS Dominate Proceedings at AGBT 2022

Mutational Signatures Profiled in Pediatric Cancers

NEW YORK – A team led by researchers in Germany has systematically analyzed mutational signatures across more than two dozen pediatric cancer types or subtypes, providing a look at everything from processes behind the tumors to potential features or vulnerabilities linked to certain tumor subtypes. Co-senior authors Natalie Jager and…

Continue Reading Mutational Signatures Profiled in Pediatric Cancers

APOBEC mutagenesis is a common process in normal human small intestine

The landscape of somatic mutation in normal human small intestinal crypts The base of each small intestinal crypt is occupied by stem cells, and the descendants of a single recent ancestor stem cell comprise most cells in each crypt19,20. Therefore, isolation of single crypts provides relatively homogeneous clones of cells…

Continue Reading APOBEC mutagenesis is a common process in normal human small intestine

SBS Language | New COVID variants can evade vaccine protections

Scientists are reacting to the sudden increase in new COVID-19 variants as it demonstrates a remarkable capacity to evade the protection provided by vaccination. The new omicron variants BA.4 and BA.5, which appear to have milder symptoms than the alpha and delta, are still a source of concern for countries…

Continue Reading SBS Language | New COVID variants can evade vaccine protections

Palimpsest deconvolution_fit() problem

Palimpsest deconvolution_fit() problem 0 I followed the official guide to calculate the exposure of each de novo signatures by using the function deconvolution_fit(), but it returned with an error as following: Error in deconvolution_fit(input_matrices = SBS_Input, input_signatures = SBS_de_novo_sigs, : promise already under evaluation: recursive default argument reference or earlier…

Continue Reading Palimpsest deconvolution_fit() problem

illumina miseq reagent Bids, RFP & Government Contracts

Reagent (Chemistry) Kits Quick View Type : Bid Notification Due : 04 Aug, 2017 (about 4 years ago) Posted : about 4 years ago Started : 28 Jul, 2017 (about 4 years ago) All of which require Reagent (Chemistry) Kits for data analysis as follows:• Sequencing by Synthesis (SBS) Kits•…

Continue Reading illumina miseq reagent Bids, RFP & Government Contracts

Color hiring Software Engineer, Bioinformatics in Remote

About Color Color’s mission is to help people lead the healthiest lives that science and medicine can offer. We launched in April 2015 with a simple, affordable genetic test to help people understand their risk for hereditary cancer. In 2017, we added coverage for hereditary heart conditions. Between them, cancer…

Continue Reading Color hiring Software Engineer, Bioinformatics in Remote

Verogen MiSeq FGx Sequencing Reagents

The MiSeq FGx System achieves exceptional data quality by employing a proprietary, reversible terminator‑based method that detects single bases as they are incorporated into massively parallel DNA strands. Fluorescent terminator dyes are imaged as each deoxynucleotide triphosphate (dNTP) is added and then cleaved to allow incorporation of the next base….

Continue Reading Verogen MiSeq FGx Sequencing Reagents

Dissemination of Mycobacterium abscessus via global transmission networks

Dataset construction, cluster identification and definition of DCCs Whole genome sequencing of two collections of isolates from Manchester, UK, and the Netherlands was carried out as previously described2. Briefly, DNA was extracted from colony sweeps of subcultured samples before to paired-end sequencing using the Illumina HiSeq platform. These samples were…

Continue Reading Dissemination of Mycobacterium abscessus via global transmission networks

The future of ‘next generation’ DNA sequencing | Business

Next Generation Sequencing has been with us for little more than a decade, but has already revolutionised biological science. According to Jonas Korlach, chief scientific officer of US-based sequencing company Pacific Biosciences (PacBio) we are now entering a golden age of sequencing technology and the advanced understanding of genetics it…

Continue Reading The future of ‘next generation’ DNA sequencing | Business

Four-color DNA sequencing by synthesis using cleavable fluorescent nucleotide reversible terminators

volume 103, issue 52, P19635-19640 2006 J. Ju, D. H. Kim, L. Bi, Q. Meng, X. Bai, Z. Li, X. Li, M. S. Marma, S. Shi, J. Wu, J. R. Edwards, A. Romu, N. J. Turro Abstract: DNA sequencing by synthesis (SBS) on a solid surface during polymerase reaction offers…

Continue Reading Four-color DNA sequencing by synthesis using cleavable fluorescent nucleotide reversible terminators

The History Of DNA Sequencing and Its Importance In Life Forms

DNA sequencing has helped develop various sectors of the economy and mainly in the health sector. DNA sequencing has helped scientists understand the causes of related genetic disorders and how to cure them. DNA sequencing has also helped scientists understand the evolution of different animal species. What about developing GMOs?…

Continue Reading The History Of DNA Sequencing and Its Importance In Life Forms